Induction of immune responses in mice after intragastric administration of Lactobacillus casei producing porcine parvovirus VP2 protein

Applied and Environmental Microbiology

Volumn 73, Issue 21, 2007, Pages 7041-7047

  Xu, Yigang ^a   Li, Yijing ^a  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; ELECTROPHORESIS; IMMUNIZATION; POLYACRYLATES; PROTEINS; VACCINES;

IMMUNE RESPONSE; PLASMIDS; PORCINE PARVOVIRUS; SODIUM DODECYL SULFATE-POLYACRYLAMIDE GEL ELECTROPHORESIS; WESTERN BLOTTING;

IMMUNOLOGY;

NEUTRALIZING ANTIBODY; PROTEIN VP2; RECOMBINANT PROTEIN; VIRUS VACCINE;

ANTIGEN; BACTERIUM; IMMUNE RESPONSE; PROTEIN; RODENT; VACCINE; VIRUS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOFLUORESCENCE; LACTOBACILLUS CASEI; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PORCINE PARVOVIRUS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

ANIMALS; CAPSID PROTEINS; DRUG ADMINISTRATION ROUTES; DRUG DELIVERY SYSTEMS; IMMUNITY, MUCOSAL; LACTOBACILLUS CASEI; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS;

LACTOBACILLUS; LACTOBACILLUS CASEI; MUS; PARVOVIRUS; PORCINE PARVOVIRUS;

EID: 35948964069     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.00436-07     Document Type: Article

References (40)

1. Alander, M., R. Satokari, R. Korpela, M. Saxelin, T. Vilpponen-Salmela, and T. Mattila-Sandholm. 1999. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl. Environ. Microbiol. 65:351-354.
2. Brandtzaeg, P. 1994. Distribution and characteristics of mucosal immunoglobulin-producing cells, p. 251-279. In O. L. Pearay and H. Metecky (ed.), Handbook of mucosal immunology. Academic Press, Boston, MA.
3. Carwright, S. F., and R. A. Huck. 1967. Viruses isolated in association with herd infertility, abortions and stillbirths in pigs. Vet. Rec. 81:196-197.
4. Challacombe, S. J. 1983. Salivary antibodies and systemic tolerance in mice after oral immunization with bacterial antigens. Ann. N. Y. Acad. Sci. 409:177-193.
5. Chang, Y. H., J. K. Kim, and H. J. Kim. 2001. Selection of a potential probiotic Lactobacillus strain and subsequent in vivo studies. Antonie Leeuwenhoek 80:193-199.
6. Chatfield, S. N., I. G. Charles, and A. J. Makoff. 1992. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus toxin vaccine. Bio/Technology 10:888-892.
7. Chen, H. 2000. Recent advances in mucosal vaccine development. J. Control. Release 67:117-128.
8. Elson, C. O., W. Ealding, and J. Lefkowiz. 1984. A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretion. J. Immunol. Methods. 67:101-108.
9. Gilliland, S. E., T. E. Staley, and I. Push. 1981. Importance of bile tolerance of Lactobacillus acidophilus used as a dietary adjunct. J. Dairy Sci. 67:3045-3051.
10. Grangette, C., H. Muller-Alouf, D. Goudercourt, M. C. Geoffroy, M. Turneer, and A. Mercenier. 2001. Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum. Infect. Immun. 69:1547-1553.
11. Ho, P. S., J. Kwang, and Y. K. Lee. 2005. Intragastric administration of Lactobacillus casei expressing transmissible gastroenteritis coronavirus spike glycoprotein induced specific antibody production. Vaccine 23:1335-1342.
12. Joo, H. S., C. R. Donaldson-Wood, R. H. Johnson, and R. S. F. Campbell. 1976. Observations of the pathogenesis of porcine parvovirus infection. Arch. Virol. 51:123-129.
13. Joo, H. S., and R. H. Johnson. 1976. Porcine parvovirus: a review. Vet. Bull. 46:653-660.
14. Jossen, K., T. Scheirlinck, F. Michiels, C. Platteeuw, P. Stanssens, and H. Joos. 1989. Characterization of a gram-positive broad-host-range plasmid isolated from Lactobacillus hilgardii. Plasmid 21:9-21.
15. Kilian, M., and M. W. Russel. 1994. Functions of mucosal immunoglobulins, p. 127-143. In P. L. Ogra, J. Mestecky, M. E. Lamm, W. Strober, J. R. McGhee, and J. Bienenstock (ed.), Handbook of mucosal immunology. Academic Press, San Diego, CA.
16. Kremer, L., L. Dupré;, G. Riveau, A. Capron, and C. Locht. 1998. Systemic and mucosal immune responses after intranasal administration of recombinant Mycobacterium bovis Bacillus Calmette-Guérin expressing glutathione S-transferase from Schistosoma haematobium. Infect. Immun. 66:5669-5676.
17. Lee, Y. K., P. S. Ho, C. S. Low, H. Arvilommi, and S. Salminen. 2004. Permanent colonization by Lactobacillus casei is hindered by the low rate of cell division in mouse gut. Appl. Environ. Microbiol. 70:670-674.
18. London, S. D. 1994. Cytotoxic lymphocytes in mucosal effector sites, p. 325-336. In P. L. Ogra, J. Mestecky, M. E. Lamm, W. Strober, J. R. McGhee, and J. Bienenstock (ed.), Handbook of mucosal immunology. Academic Press, San Diego, CA.
19. Maassen, C. B. M., J. D. Laman, and M. J. Heyne den Bak-Glashouwer. 1999. Instruments for oral disease-intervention strategies: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis. Vaccine 17:2117-2128.
20. McGhee, J. R., J. Mestecky, M. T. Dertzbaugh, J. K. Eldridge, M. Hirasawa, and H. Kiyono. 1992. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10:75-88.
21. Medina, E., and C. A. Guzman. 2001. Use of live bacterial vaccine vectors for antigen delivery: potential and limitation. Vaccine 19:1573-1580.
22. Mengeling, W. L., and R. C. Cutlip. 1975. Pathogenesis of in utero infection: experimental infection of five-week-old porcine fetuses with porcine parvovirus. Am. J. Vet. Res. 36:1173-1177.
23. Mestecky, J. 1987. The common mucosal immune system and current strategies for induction of immune responses in external secretion. J. Clin. Immunol. 7:265-276.
24. Molitor, T. W., H. S. Joo, and M. S. Collett. 1983. Porcine parvovirus: virus purification and structural and antigenic properties of virion polypeptides. J. Virol. 45:842-854.
25. Molitor, T. W., H. S. Joo, and M. S. Collett. 1984. Porcine parvovirus DNA: characterization of genomic and replicative form DNA of two virus isolates. Virology 137:241-254.
26. Molitor, T. W., and H. S. Joo. 1990. Clinical and pathological features of porcine parvovirus-related disease and its diagnosis, p. 135-150. In P. Tijssen (ed.), Handbook of parvoviruses. CRC Press, Boca Raton, FL.
27. Ogawa, T., Y. Asai, K. Yasuda, and H. Sakamoto. 2005. Oral immunoadjuvant activity of a new symbiotic Lactobacillus casei subsp. casei in conjunction with dextran in BALB/c mice. Nutr. Res. 25:295-304.
28. Oliveiria, M. L. S., V. Monedero, E. N. Miyaji, L. C. C. Leite, P. L. Ho, and G. Perez-Martinez. 2003. Expression of Streptococcus pneumoniae antigens, PsaA (pneumococcal surface antigen A) and PspA (pneumococcal surface protein A) by Lactobacillus casei. FEMS Microbiol. Lett. 227:25-31.
29. Perdigon, G., R. Fuller, and R. Raya. 2001. Lactic acid bacteria and their effect on the immune system. Curr. Issues Intest. Microbiol. 1:27-42.
30. Pouwels, P. H., R. J. Leer, and W. J. Boersma. 1996. The potential of Lactobacillus as a carrier for oral immunization: development and preliminary characterization of vector systems for targeted delivery of antigen. Bio/Technology 44:183-192.
31. Reveneau, N., M. C. Geoffroy, C. Locht, P. Chagnaud, and A. Mercenier. 2002. Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations. Vaccine 20:1769-1777.
32. Ridpath, J. F., and W. L. Mengeling. 1988. Uptake of porcine parvovirus into host and nonhost cells suggests host specificity is determined by intracellular factors. Virus Res. 10:17-28.
33. Robinson, K., L. M. Chamberlain, K. M. Schofield, J. M. Wells, and R. W. F. Le Page. 1997. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat. Biotechnol. 15:653-657.
34. Ryan, E. T., J. R. Butterton, R. N. Smith, P. A. Carroll, T. I. Crean, and S. B. Calderwood. 1997. Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain. Infect. Immun. 65:2941-2949.
35. Salminen, S., M. Playne, and Y. K. Lee. 2004. Successful probiotic lactobacilli: human studies on probiotic efficacy, p. 13-32. In C. Shortt (ed.), Functional dairy products. Technomic, Lancaster, United Kingdom.
36. Sambrook J., E. F. Fritisch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
37. Scheppler, L., M. Vogel, A. W. Zuercher, M. Zuercher, J. E. Germond, S. M. Miescher, and B. M. Stadler. 2002. Recombinant Lactobacillus johnsonii as a mucosal vaccine delivery vehicle. Vaccine 20:2913-2920.
38. Sedlik, C., M. Saron, J. Sarraseca, I. Casal, and C. Leclerc. 1997. Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells. Proc. Natl. Acad. Sci. USA 94:7503-7508.
39. Underdown, B. J., and J. Mestecky. 1994. Mucosal immunoglobulin, p. 79-98. In P. Ogra, J. Mestecky, M. E. Lamm, W. Strober, and J. R. Mcghee (ed.), Handbook of mucosal immunology. Academic Press, Boston, MA.
40. Weston, S. A., and C. R. Parish. 1990. New fluorescent dyes for lymphocyte migration studies: analysis by flow cytometry and fluorescent microscopy. J. Immunol. Methods 133:87-97.